HOMB:NYSEHome BancShares, Inc. Analysis
Data as of 2026-05-19 - not real-time
$26.09
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Home BancShares trades near the lower end of its 52‑week range, offering a modest upside relative to its intrinsic estimate. The stock’s price‑to‑earnings multiple sits well beneath the sector average, pointing to a valuation advantage. Strong operating margins and a solid return on equity underscore a profitable business model. A dividend yield that outpaces many peers, coupled with a payout ratio comfortably below half of earnings, suggests dividend sustainability. The balance sheet features ample cash relative to debt, providing a cushion for loan growth and potential acquisitions. Analyst price targets cluster above the current level, hinting at upside potential.
Technically, the MACD line sits below its signal, and volume has been on a downtrend, signaling short‑term weakness. The RSI hovers in the neutral zone, while price is testing a key support level that has held in recent months. Elevated volatility and a beta below the market suggest price swings may be sharper than the broader index but still moderated. Given the blend of attractive dividend income, relative valuation, and a stable earnings profile, the stock is positioned as a defensive value play. Investors should monitor loan growth trends and any shifts in regional banking sentiment before taking larger positions.
Technically, the MACD line sits below its signal, and volume has been on a downtrend, signaling short‑term weakness. The RSI hovers in the neutral zone, while price is testing a key support level that has held in recent months. Elevated volatility and a beta below the market suggest price swings may be sharper than the broader index but still moderated. Given the blend of attractive dividend income, relative valuation, and a stable earnings profile, the stock is positioned as a defensive value play. Investors should monitor loan growth trends and any shifts in regional banking sentiment before taking larger positions.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bearish MACD alignment
- decreasing trading volume
- price testing a near‑term support level
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- attractive dividend yield relative to peers
- valuation advantage versus industry PE
- strong operating margins and cash position
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- stable earnings and solid ROE
- low beta indicating moderated market sensitivity
- sustainable dividend policy with room for growth
Key Metrics & Analysis
Financial Health
Revenue Growth2.40%
Profit Margin44.52%
P/E Ratio10.7
ROE11.40%
ROA2.07%
P/B Ratio1.2
Op. Cash Flow$433.1M
Industry P/E16.7
Technical Analysis
TrendBearish
RSI42.6
Support$25.50
Resistance$27.48
MA 20$26.53
MA 50$26.78
MA 200$27.98
MACDBearish
VolumeDecreasing
Fear & Greed Index89.61
Valuation
Fair Value$22.36
Target Price$31.29
Upside/Downside19.91%
GradeFair
TypeValue
Dividend Yield3.22%
Risk Assessment
Beta0.78
Volatility21.70%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.